Plans to open new R&D lab

Scroll Down

We are extremely grateful to the City of Fishers and to the IEDC for making Fishers a supportive place to grow our business,” said Bill Vincent, CEO of Genezen. “Gene and cell therapies have shown amazing potential in treating cancer and rare genetic disorders, but manufacturing capacity has proven to be a bottleneck in advancing these therapies to help patients. Genezen’s expansion will not only help alleviate this challenge but will provide an anchor for developing other gene therapy and biotech companies in central Indiana.

See the full story on Inside Indiana Business.

You may also be interested in...

Genezen Appoints New CEO as GMP…

Genezen Inc., a cell and gene therapy Contract Development and Manufacturing...

Read more

A time of flux: opportunities and…

In this blog, Katherine Moynihan, VP of Business Development and Marketing...

Read more

Meeting Demand for Biologics

With the recent tendency of drug developers to outsource their formulation...

Read more

Balancing Biopharma’s Pressing Priorities

With intense pressure continuing to be placed upon the pharmaceutical industry...

Read more